Literature DB >> 17764386

Folate and ApoE DNA methylation induced by homocysteine in human monocytes.

Jiang Yi-Deng1, Sun Tao, Zhang Hui-Ping, Xiong Jian-Tuan, Cao Jun, Li Gui-Zhong, Wang Shu-Ren.   

Abstract

Homocysteine (Hcy) is an important and independent risk factor for arteriosclerosis, and apolipoprotein E (ApoE) is an important gene of anti atherosclerosis, but the characteristics and their key links that are involved in their pathogenic mechanisms are still poorly understood. The objective of the present study was to investigate the effects of Hcy and folate on ApoE as well as the underlying mechanism of ApoE expression induced by Hcy in monocytes. When clinically relevant concentrations of Hcy and folate were added to the cultured monocytes for 4 days, we found that clinically relevant Hcy (100 microM) may increase the levels of total cholesterol (TC), free cholesterol (FC), and cholesteryl ester (CE), and also decrease ApoE mRNA, protein expressions, leading to 34.28%, 45.00% in cultured primary human monocytes in comparison to the positive group. The effects of Hcy were primarily mediated by C-5 MTase, because Hcy could upregulate the activity of C-5 MTase and then accelerate DNA methylation of ApoE. However, folate decreased the levels of TC, FC, and CE (p < 0.001) and increased the ApoE expression; as to say, folate primarily repressed the effects of DNA methylation induced by Hcy and reduced anti atherosclerosis. In conclusion, these results suggested that ApoE DNA methylation that is induced by Hcy may play a potential role for ApoE expression in atherosclerosis. Folate has beneficial effects for anti atherosclerosis, and it may become a therapeutic target for preventing Hcy-induced atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764386     DOI: 10.1089/dna.2007.0619

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  13 in total

Review 1.  Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets.

Authors:  Yi Fu; Xian Wang; Wei Kong
Journal:  Br J Pharmacol       Date:  2017-09-22       Impact factor: 8.739

2.  Vascular damage in kidney disease: beyond hypertension.

Authors:  Andréa E M Stinghen; Roberto Pecoits-Filho
Journal:  Int J Hypertens       Date:  2011-08-14       Impact factor: 2.420

3.  Genetic variants modify the effect of age on APOE methylation in the Genetics of Lipid Lowering Drugs and Diet Network study.

Authors:  Yiyi Ma; Caren E Smith; Chao-Qiang Lai; Marguerite R Irvin; Laurence D Parnell; Yu-Chi Lee; Lucia Pham; Stella Aslibekyan; Steven A Claas; Michael Y Tsai; Ingrid B Borecki; Edmond K Kabagambe; Silvia Berciano; José M Ordovás; Devin M Absher; Donna K Arnett
Journal:  Aging Cell       Date:  2014-12-04       Impact factor: 9.304

4.  Homocysteine Triggers Inflammatory Responses in Macrophages through Inhibiting CSE-H2S Signaling via DNA Hypermethylation of CSE Promoter.

Authors:  Jiao-Jiao Li; Qian Li; Hua-Ping Du; Ya-Li Wang; Shou-Jiang You; Fen Wang; Xing-Shun Xu; Jian Cheng; Yong-Jun Cao; Chun-Feng Liu; Li-Fang Hu
Journal:  Int J Mol Sci       Date:  2015-06-03       Impact factor: 5.923

5.  Homocysteine thiolactone and N-homocysteinylated protein induce pro-atherogenic changes in gene expression in human vascular endothelial cells.

Authors:  Dorota Gurda; Luiza Handschuh; Weronika Kotkowiak; Hieronim Jakubowski
Journal:  Amino Acids       Date:  2015-03-24       Impact factor: 3.520

Review 6.  Epigenetics in atherosclerosis and inflammation.

Authors:  Rutger J Wierda; Sacha B Geutskens; J Wouter Jukema; Paul H A Quax; Peter J van den Elsen
Journal:  J Cell Mol Med       Date:  2010-01-30       Impact factor: 5.310

Review 7.  Notable epigenetic role of hyperhomocysteinemia in atherogenesis.

Authors:  Shuyu Zhou; Zhizhong Zhang; Gelin Xu
Journal:  Lipids Health Dis       Date:  2014-08-21       Impact factor: 3.876

8.  Vitamin D, Homocysteine, and Folate in Subcortical Vascular Dementia and Alzheimer Dementia.

Authors:  Rita Moretti; Paola Caruso; Matteo Dal Ben; Corrado Conti; Silvia Gazzin; Claudio Tiribelli
Journal:  Front Aging Neurosci       Date:  2017-05-30       Impact factor: 5.750

9.  Pharmacological inhibition of EZH2 by GSK126 decreases atherosclerosis by modulating foam cell formation and monocyte adhesion in apolipoprotein E-deficient mice.

Authors:  Xianjing Wei; Ying Zhang; Lianna Xie; Kaijun Wang; Xiaoqing Wang
Journal:  Exp Ther Med       Date:  2021-06-06       Impact factor: 2.447

Review 10.  Epigenetic regulation of cholesterol homeostasis.

Authors:  Steve Meaney
Journal:  Front Genet       Date:  2014-09-24       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.